UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.168

Sortiert nach

Programmed death-1 blockade in mismatch repair deficient colorectal cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.103-103

2016

Link zum Volltext

Verfügbarkeit prüfen

Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials

Journal of clinical oncology, 2018-09, Vol.36 (26), p.2693-2701

2018

Link zum Volltext

Verfügbarkeit prüfen

COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2022-10, Vol.40 (29), p.JCO2200227-3393

2022

Link zum Volltext

Verfügbarkeit prüfen

Adaptive expertise for medical oncology fellows: How to foster evidence-based medicine mastery

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e23015-e23015

2022

Link zum Volltext

Verfügbarkeit prüfen

Novel biomarkers to predict chronic kidney disease and hypertension at 3 and 12 months post-cisplatin

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e22003-e22003

2023

Link zum Volltext

Verfügbarkeit prüfen

Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer

Journal of clinical oncology, 2020-05, Vol.38 (15), p.1676-1684

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment patterns and outcomes of diffuse alveolar hemorrhage: Findings from a single-center retrospective study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e19063-e19063

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical practice guideline descriptions of oncologic drugs granted FDA accelerated approval: A cross-sectional study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1590-1590

2023

Link zum Volltext

Verfügbarkeit prüfen

Emergency room presentation of lung cancer as a highly practical prognostic marker for consideration in clinical trials: A SEER database analysis

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e19032-e19032

2020

Link zum Volltext

Verfügbarkeit prüfen

Resident Inpatient Curriculum for Oncology (RICO): Results of a targeted needs assessment performed in the Osler Internal Medicine Residency Program

Journal of clinical oncology, 2022-10, Vol.40 (28_suppl), p.365-365

2022

Link zum Volltext

Verfügbarkeit prüfen

The impact of neoadjuvant treatment (NAT) on surgery in early breast cancer (EBC): A real-world data study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e12609-e12609

2022

Link zum Volltext

Verfügbarkeit prüfen

Improving resident education on the inpatient solid tumor oncology rotation through development of an asynchronous video curriculum

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e23014-e23014

2022

Link zum Volltext

Verfügbarkeit prüfen

Genomic profile of intrahepatic cholangiocarcinoma with MTAP loss

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4102-4102

2022

Link zum Volltext

Verfügbarkeit prüfen

Geographic disparities in breast cancer mortality and place of death in the United States from 2003 to 2019

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.12034-12034

2022

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of virtual stress management and resiliency training (SMART) for oncology fellows during the COVID-19 pandemic

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.11016-11016

2022

Link zum Volltext

Verfügbarkeit prüfen

Do genetic testing criteria identify individuals with Lynch syndrome prior to cancer diagnoses?

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e13158-e13158

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of genomic alterations measured in circulating tumor DNA (ctDNA) on clinical response to telisotuzumab vedotin treatment in patients with non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9032-9032

2023

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive genomic profiling (CGP) of clinically advanced and metastatic cutaneous adnexal carcinomas (CAs; MCADCA): A genomic landscape study

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9587-9587

2023

Link zum Volltext

Verfügbarkeit prüfen

Association between patient-reported outcomes and therapeutic outcomes in patients with breast cancer: A pooled individual-participant data analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.530-530

2023

Link zum Volltext

Verfügbarkeit prüfen

Fear of cancer recurrence inventory scores and their correlation with quality of life and stress levels in breast cancer survivors

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e24073-e24073

2023

Link zum Volltext

Verfügbarkeit prüfen

How did the COVID-19 pandemic affect the management of patients with cancer? What is the impact of anti-cancer medications on the immune response to the COVID-19 vaccinations?

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e24193-e24193

2023

Link zum Volltext

Verfügbarkeit prüfen

Characterizing KRAS allele variants within biliary tract cancers

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4088-4088

2023

Link zum Volltext

Verfügbarkeit prüfen

Documentation of goals of care discussions: Lessons from the Improving Goal Concordant Care Collaborative

Journal of clinical oncology, 2021-10, Vol.39 (28_suppl), p.166-166

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase I trial of androgen deprivation, darolutamide, and ipatasertib in a safety cohort with castration-resistant prostate cancer (ADDITION)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.174-174

2023

Link zum Volltext

Verfügbarkeit prüfen

A multi-center, prospective, observational study of patients with prostate cancer being treated with relugolix: OPTYX

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.TPS398-TPS398

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.168

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Zeitschrift / SerieJournal Of Clinical Oncology

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(1.168)

Publikationsform

Artikel
(1.168)

Sprache

Englisch
(1.168)
Japanisch
(18)

Erscheinungsjahr

n.n

Kollektion

EZB Electronic Journals Library
(1.168)
Journals@Ovid Complete
(1.168)
NUS Single-Journal Subscriptions
(1.168)
IngentaConnect Journals
(242)
Ingenta.com
(242)

Menü

Weitere Dienste

Einstellungen

Programmed death-1 blockade in mismatch repair deficient colorectal cancer

Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials

COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer

Adaptive expertise for medical oncology fellows: How to foster evidence-based medicine mastery

Novel biomarkers to predict chronic kidney disease and hypertension at 3 and 12 months post-cisplatin

Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer

Treatment patterns and outcomes of diffuse alveolar hemorrhage: Findings from a single-center retrospective study

Clinical practice guideline descriptions of oncologic drugs granted FDA accelerated approval: A cross-sectional study

Emergency room presentation of lung cancer as a highly practical prognostic marker for consideration in clinical trials: A SEER database analysis

Resident Inpatient Curriculum for Oncology (RICO): Results of a targeted needs assessment performed in the Osler Internal Medicine Residency Program

The impact of neoadjuvant treatment (NAT) on surgery in early breast cancer (EBC): A real-world data study

Improving resident education on the inpatient solid tumor oncology rotation through development of an asynchronous video curriculum

Genomic profile of intrahepatic cholangiocarcinoma with MTAP loss

Geographic disparities in breast cancer mortality and place of death in the United States from 2003 to 2019

Feasibility of virtual stress management and resiliency training (SMART) for oncology fellows during the COVID-19 pandemic

Do genetic testing criteria identify individuals with Lynch syndrome prior to cancer diagnoses?

Impact of genomic alterations measured in circulating tumor DNA (ctDNA) on clinical response to telisotuzumab vedotin treatment in patients with non-small cell lung cancer (NSCLC)

Comprehensive genomic profiling (CGP) of clinically advanced and metastatic cutaneous adnexal carcinomas (CAs; MCADCA): A genomic landscape study

Association between patient-reported outcomes and therapeutic outcomes in patients with breast cancer: A pooled individual-participant data analysis

Fear of cancer recurrence inventory scores and their correlation with quality of life and stress levels in breast cancer survivors

How did the COVID-19 pandemic affect the management of patients with cancer? What is the impact of anti-cancer medications on the immune response to the COVID-19 vaccinations?

Characterizing KRAS allele variants within biliary tract cancers

Documentation of goals of care discussions: Lessons from the Improving Goal Concordant Care Collaborative

A phase I trial of androgen deprivation, darolutamide, and ipatasertib in a safety cohort with castration-resistant prostate cancer (ADDITION)

A multi-center, prospective, observational study of patients with prostate cancer being treated with relugolix: OPTYX

Aktive Filter

Suchergebnisse filtern